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EFFECTS OF GLUTAMINE SUPPLEMENTATION ON MAXIMAL 
PERFORMANCE AND RECOVERY FROM HIGH-INTENSITY EXERCISE 
Mandy Lynn Jacobs 
August 7, 2008 
The purpose of this study was to determine the effects of acute glutamine 
supplementation on maximal performance and recovery from high-intensity exercise. In 
a placebo-controlled, crossover study, seven (six males and one female) healthy subjects 
performed maximal treadmill exercise one-hour after the ingestion of 0.03 g·kg body 
mass-1 glutamine mixed with caffeine-free fruit juice or placebo. Expired gases, 
respiratory exchange ratios (RER), heart rate (HR), ratings of perceived exertion (RPE) 
and blood samples were collected pre-, during, and post-exercise. In addition, urine and 
saliva samples were obtained pre- and post-exercise. No significant differences in 
oxygen consumption, C02 production, HR, RPE, urine and saliva pH were found 
between treatments. The GLN trial (1.20 ± 0.07) produced a higher RER value than the 
PLC trial (1.11 ± 0.09) at 5-min post-exercise, resulting in a significant difference (p = 
0.042). However, the significant difference was due to the inclusion of the female in the 
group analysis. This study demonstrates that acute glutamine supplementation does not 
enhance maximal performance or recovery from high-intensity treadmill running. 
IV 
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In today's culture, athletes are continuously searching for means beyond 
traditional training techniques that will give them an additional advantage over their 
competitors. Thus, athletes often rely on dietary supplementation in order to improve 
their performance. Although limited information is available on the extent of dietary 
supplement use among athletes, in 1999 it was estimated that the annual sales of 
supplement products in the United States totaled $12 billion!. Athletes account for a 
significant fraction of the total market and a wide range of products are aimed at both the 
active population and at those engaged in competitive sport. The problem with this 
reliance on dietary supplements is that the industry is completely unregulated by the 
government in the United States due to the Dietary Supplement Health and Education Act 
of 199457. As a consequence, an abundance of supplement products of dubious value, 
content and quality are now available to athletes all over the world 105. More recently 
gaining popularity among athletes are individual amino acids- specifically, glutamine-
due to its use in the area of human nutrition133• Results of clinical studies have suggested 
that glutamine supplementation may improve nitrogen balance54 and support immune 
function! 02. 
In a brief review of glutamine as a potential supplement for athletes, Antonio and 
Street suggest that glutamine might provide ergogenic effects for athletes that engage in 
intense exercise training4. They hypothesize that when athletes engage in high-intensity 
exercise, a significant increase in plasma lactate and hydrogen ion (H+) concentration 
occurs within the body due to glycolysis. This increased production ofH+ can cause a 
fall in plasma pH from approximately 7.4 to 6.9-7.0, resulting in a state known as 
metabolic acidosis (pH < 7.35). The associated fall in pH with acidosis can hinder 
muscular contraction and ultimately performance by limiting the rate of resynthesis of 
ATP by inhibiting key glycolytic enzymes, such as phosphfructokinase29, 125; inhibiting 
the release of calcium ions from the sarcoplasmic reticulum and the binding of these ions 
to the protein troponin33, 37; and impairing the neural impulse propagation32, 124. Under 
normal physiological conditions, glutamine is converted to a-ketoglutarate, which 
produces ammonium ions (NH4 +) that in turn buffer the acidotic state. However, when 
the decrease in pH is too drastic for this buffering system too work efficiently, such as 
during high-intensity exercise, the athlete's performance and recovery may be 
compromised56 . 
Past studies have demonstrated that increasing plasma pH via sodium bicarbonate 
d· . . .. b" c 92 93 103 144 15 18 or so mm CItrate mgestIOn can Improve anaero IC exerCIse perlormance ' , , " , 
27,90,125. Hence some researchers have stated that it is logical to believe glutamine 
supplementation would also be able to increase pH as well due to its base generating 
potentiae, 56. However, very few studies have been conducted to investigate the effects 
of glutamine supplementation on athletic performance and/or recovery from high-
intensity exercise3, 56,104. Making matters even more complicated, the studies have solely 
examined the effects of glutamine supplementation on short intermittent bouts of 
exercise, such as those observed during weightlifting3 and cycling (sprints)56, 104. No 
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reported literature was found examining the effects of glutamine supplementation on 
maximal performance and recovery during high-intensity running. 
Purpose of the Study 
The purpose of this study was to determine if glutamine supplementation has an 
ergogenic effect on high-intensity treadmill running. 
Primary Aim: 
1) To determine the effects of acute glutamine supplementation on plasma 
glutamine concentration and lactate during and after a high-intensity running 
protocol. 
Secondary Aims: 
1) To determine the effects of acute glutamine supplementation on maximal 
performance (V02max) and associated parameters (ratings of perceived exertion, 
heart rate, CO2 production) during a high-intensity running protocol. 
2) To determine the effects of acute glutamine supplementation on recovery 
parameters (02 consumption, CO2 production, heart rate, respiratory exchange 
ratio) after a high-intensity running protocol. 
3) To further investigate the changes in plasma glutamine concentration during 
and after high-intensity running. 
Hypotheses 
The following hypotheses will be tested: 
Primary Hypothesis: 
1) The acute supplementation of glutamine will increase plasma glutamine concentration 
and decrease lactate levels during and after high-intensity running via a buffering effect. 
3 
Secondary Hypotheses: 
1) The acute supplementation of glutamine will increase V02max and decrease 
ratings of perceived exertion during exercise. 
2) The acute supplementation of glutamine will increase CO2 production and 
respiratory exchange ratios post-exercise. 
3) Plasma glutamine concentrations will increase during and post-exercise from 
resting (baseline) values. 
Significance of Study 
This study is significant as it will determine if acute glutamine supplementation 
one-hour prior to exercise has an ergogenic effect on high-intensity running. Several 
studies have indicated the use of oral glutamine supplementation to improve exercise 
performance during high-intensity and prolonged exercise. To date no literature has 
addressed the potential effects of glutamine supplementation on maximal performance 
and recovery from high-intensity treadmill running. This research is important in 




Glutamine is a five-carbon amino acid76 that is found in the human body at 
relatively high levels 117. In fact, glutamine is the most abundant non-essential amino acid 
in human plasma76, with normal plasma concentrations ranging between 500 and 750 
).1mol/L 40. There are two principal enzymes of glutamine metabolism: glutaminase and 
glutamine synthetase. Glutaminase catalyses the hydrolysis of glutamine to glutamate 
and ammonia, and glutamine sythetase catalyses the synthesis of glutamine from 
ammonia and glutamate. The direction and rate of flux through the substrate cycle is 
tissue-dependent, as different tissues vary considerably in the forward and reverse rates 
of reaction. Therefore, the net direction of the reaction will determine whether a 
particular tissue is a net consumer or producer75, 97. A constant level is maintained under 
normal conditions due to a balance between release and utilization of glutamine by 
various organs within the body. By simultaneously sampling arterial and venous blood 
various organs, one can classify an organ as either predominantly a consumer or a 
producer of glutamine I 17 . Those organs considered to be involved in the synthesis of 
glutamine include primarily skeletal muscle, the lungs, liver, brain and possibly adipose 
tissuel17 . The main consumers appear to be the kidneys, intestines and cells of the 
immune system 40,75,97, 117. Under certain conditions, the liver may also become a net 
consumer of glutamine I 36. 
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Although numerous organs within the body use glutamine as a fuel, it is 
prominently used by the immune system and gastrointestinal tract. In addition, glutamine 
accounts for more than 60% of the total intramuscular free amino acid122 and because 
skeletal muscle represents a large mass of tissue, it is quantitatively the most important 
site of glutamine synthesis despite the fact that glutamine synthetase activity is relatively 
low per unit mass in skeletal muscle l40. 
Glutamine fulfills many vital roles in the tissues and organs of the body. Such 
roles include maintenance of the acid-base balance during acidosis28,46, 106, transfer of 
nitrogen between organs and detoxification of ammonia97, acting as a nitrogen precursor 
for the synthesis of nucleotides 75, a fuel for gut mucosal cells55, 123, 145, 146 and cells ofthe 
immune system7 and a possible direct regulator of protein synthesis and degradation85. 
As previously stated, plasma glutamine concentrations remain at constant level 
under normal physiological conditions. Most naturally occurring food proteins contain 
four to eight percent of their amino acid residues as glutamine, so the daily consumption 
of glutamine is usually less than 10 gramsl22. However, during various catabolic states, 
such as sepsis9, surgerl4, 65,108, trauma, burns lO2 and acidosisl42, glutamine homeostasis 
is placed under stress, and glutamine reserves are reduced. In addition, some studies 
have shown similar states of depletion due to both prolonged and high-intensity exercise 
stress23,24. It has been suggested that it may be necessary to consume between 20 and 40 
grams of glutamine per day to maintain homeostasis after a severe catabolic insule
6
. 
The Effects of Exercise on Plasma Glutamine Concentrations 
Skeletal muscle is quantitatively the most important source of glutamine since not 
only can it synthesize glutamine but it also provides storage23. The store of free glutamine 
6 
within the skeletal muscle is estimated at 20 mmoliL of intracellular water I 3, which 
accounts for the majority of the body's total glutamine stores I22 . The rate of glutamine 
synthesis in human skeletal muscle is higher than that for any other amino acid and in the 
fed state is approximately 50 mmol/h44, 137. Parry-Billings et al. speculates that this high 
synthetic rate is essential to maintain glutamine homeostasis due to the fact that skeletal 
muscle provides the majority of glutamine required by other tissues lOo• Thus, it is 
suggested that the failure of skeletal muscle to provide sufficient glutamine due to 
exercise stress could result in a hindered performance and state of recovery. 
Plasma Glutamine Measurement 
Unlike the many other amino acids, glutamine has been shown to be relatively 
unstable in aqueous solution95 and is known to readily break down to glutamate and 
ammonia in the presence of heat, as well as either strong acidic or basic environmentS. 
Specific preparations of samples and storage methods have been developed to minimize 
degredation 117. To date, three different measurement techniques are primarily used for 
the quantification of glutamine levels: enzymatic methodologyl, 35, 83,101, 118, 119, 146, 149, 
high performance liquid chromatography (HPLC)IO, 12,30,36,47,68, 110, 115, and bioassay70, 
116 Q 'fi . fl' b . I . fl' . uantI catIOn 0 g utamme y enzyme assay mvo ves converSIOn 0 g utamme to 
glutamate83, the subsequent degradation of the product to a-ketoglutarate at pH 9.014, and 
the concomitant conversion of nicotinamide adenine dinucleotide (NAD+) to its reduced 
form NADH, which is detected spectrophotometrically. The plasma level of glutamate is 
then subtracted to obtain the original level of plasma glutamine, on the principal that the 
conversion of glutamine to glutamate is on a molar to molar basis 117. Automated amino 
acid analyzers have also been developed, based on this enzyme assal
l
. HPLC has also 
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been used to detennine plasma glutamine 1 0, 110 but generally require acidified samples in 
analytical procedures 1 35 • The recently developed bioassay method, uses a strain of 
Escherichia coli (E. coli) known to be dependent on glutamine for replication91 • Growth 
of E. coli has been shown to be directly proportional to the amount of glutamine 
available?o. The nonnal range of values obtained for human plasma samples differ to 
some degree depending on the methodology used, thus it is important to consider which 
methodology is being used when comparing particular studies with one anotherll? 
Exercise & Plasma Glutamine Concentrations 
There have been various studies that investigated the effects of exercise on plasma 
glutamine concentrations (Table 1), although a clear consensus does not exist within the 
literature. Data has shown that during exercise, plasma glutamine concentrations may 
increase, decrease or remain unchanged depending on the type, duration, and intensity of 
exercise. Walsh et al. feels the equivocal data is also due to the nutritional status of the 
individuals and differences in measurement technique, blood sampling times and sample 
storage 137 • 
Prolonged Exercise 
Studies that have analyzed the effects of prolonged exercise on plasma glutamine 
concentration have led to ambiguous conclusions. In a recent experiment, continuous 
cycling at 55% of maximal oxygen consumption (V02max) for three hours in 18 healthy 
men led to a 23% fall in plasma glutamine one hour after exercise (580 /lmol/L pre-
exercise compared with 447 /lmol/L after one hour ofrecovery)ll2. Producing similar 
results, Rennie et al. monitored plasma glutamine levels for 270-minutes following 195-
minutes of cycling at 50% V02max
llO
. A fall from 557 /lmollL at rest to 470 /lmollL 
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immediately after exercise was reported. After two hours of recovery, plasma glutamine 
levels continued to fall its' lowest level of391 Ilmol/L, but after 270-minutes of recovery, 
levels increased to 482 IlmoliL 110. In addition, Parry-Billings et al. reported a 16% 
decrease in mean circulating glutamine levels in 22 trained distance runners following a 
marathon race (592 to 495 IlmollL)IOI. 
In contrast, both a 30km treadmill run and cycle ride to exhaustion at 73% 
V02max had no effect on plasma glutamine levels when samples were collected 
immediately before and after exerciselOl • Similarly, Lehmann et al. reported no changes 
in venous plasma glutamine concentrations following an ultra triathlon (7.5km 
swimming, 360km cycling and 85km running)8o. However, in that study blood samples 
were taken within 30 minutes of completing the race and it is possible that the glutamine 
concentration may have decreased after this time 114. In addition, continuous cycling to 
exhaustion at 80% V02max (which occurred within one hour) in 18 healthy men did not 
alter the plasma glutamine level at exercise test cessation from the pre-exercise valuell2. 
AcutelHigh-Intensity Exercise 
Numerous studies have demonstrated an increase in plasma glutamine 
concentration following brief (less than one hour) high-intensity exercise in humans. 
Eriksson et al. found plasma glutamine levels increased from 538 Ilmoi/L to 666 IlmoliL 
during 45-minutes of incremental exercise at 80% V02max36 and Babij et al. observed 
increases from 575 Ilmoi/L at rest to 734 IlmoliL during exercise at 100% V02maxlO• 
These findings were further supported by a study conducted by Parry-Billings et al. in 
which a series often six-seconds sprints resulted in an increase in plasma glutamine 




and Terjung claim that an increase in plasma glutamine concentrations during acute 
exercise suggest that glutamate acts as a sink for NH3 in the formation of glutamine 
during enhanced ammonia (NH3) production, which consequently occurs during high-
intensity exercise due to an increased reliance on anaerobic metabolism and an increased 
production of lactic acid62. 
In contrast, Keast et al. found a significant decrease in plasma glutamine levels 
due to acute high-intensity exercise. The study consisted of seven trained males that 
participated in fifteen one-minute bouts at 90% V02max on a treadmill, which resulted in 
a 44% decrease in plasma glutamine levels immediately after exercise. Additionally, the 
same seven subjects showed a decrease of 55% immediately after participating in fifteen 
one-minute bouts at 120% V02max on a treadmilCo. There has been one study to date 
that has aimed to establish the pattern and time course of plasma glutamine recovery after 
exercise and any diurnal variations. Kargotich et al. conducted a study in which eight 
elite male swimmers completed IS x 100m intervals at 70% and 95% of their maximal 
exercise intensity. Venous blood samples were obtained at rest, immediately post-
exercise and 30-minutes, 60-minutes, 120-minutes and ISO-minutes post-exercise. No 
changes were observed in plasma glutamine following the 70% interval, however, 
following the 95% interval, the means plasma glutamine concentration changed 
significantly from 1140 /lmol/L at rest to 1002 /lmollL post-exercise. This data suggests 
that at least six hours between intensive training sessions must be allocated to ensure 
adequate plasma glutamine recovery. This study further emphasizes the necessity to 
establish appropriate times within training programs to screen for specific training related 




Recovery from Exercise 
Similar to the changes that occur during exercise, the return of plasma glutamine 
levels to pre-exercise values during recovery (post-exercise) are dependent upon the 
intensity and duration of the exercise bout. Decombaz et al. reported that the changes in 
plasma glutamine levels observed in trained athletes following a 100km run had not 
returned to pre-exercise values even after 24 hours of recoveri I, In addition, during a 
225-minute exercise session at 50% V02max, a mean resting glutamine level of 557 
~mol/L, fell to 470 ~mol/L immediately after exercise and was further decreased to 391 
~mol/L after 120-minutes of recovery, It had increase to only 482 ~mol/L after 270 
minutes of recovery I 10 , Similarly, in a study involving eight trained male swimmers 
whom participated in fifteen one-minute bouts at 95% V02max, the lowest levels were 
observed between four and six hours after exercise, 84 and 86% of the resting plasma 
glutamine level respectively66, Consequently, it has been suggested that considerable 
periods of recovery may be required between exercise training sessions, particularly those 
of high-intensity exercise, to allow complete recovery of plasma glutamine levels ll7, 
Moreover, following a triathlon in which eight volunteers swam 2,5km, cycled 81km and 
ran 19km, mean serum glutamine levels declined from 468 ~mol/L (pre-race) to 318 
~mol/L at two-hours post-exercisel14, 
The fall in plasma glutamine observed post-exercise may be due to an increased 
k f 1 'b h k'd' b f~ b I' 'd' 96 141 143 upta e 0 g utamme y tel neys m attempt to u ler meta 0 lC aCI OSIS' , , 
Acidosis can arise from increased lactic acid production associated with high-intensity 
exercise and an accumulation of other organic acids including free fatty acids, 
acetoacetate and 3-hydroxybutyrate, Ammonia production in the kidneys and its 
II 
secretion into the distal tubules together with excretion of excess protons in the urine 
protects against acidosis. By the action of glutaminase, glutamine is hydrolyzed to 
glutamate in the distal tubules, producing NH3, which can be combined with a hydrogen 
ion to form ammonium ions 137• Alternatively, the immune system may be stimulated to 
increase glutamine utilization as a result of exercise-induced early inflammation and 
cytokine activation109, 121, concomitant with lymphocyte activationl9 and mobilization of 
natural killer cells with an increased glutamine oxidation rate42• It has also been 
postulated that glutamine uptake by the liver and gastrointestinal tract for 
gluconeogenesis occurs simultaneously with constant or decreased glutamine release by 
muscle, resulting in a decreased post-exercise plasma glutamine concentration137• 
Overtraining Syndrome 
Given the changes in plasma glutamine levels that are commonly observed after 
prolonged and/or high-intensity exercise and the function of glutamine in immune cells, 
the role of glutamine in overtraining has recently gained attention52• The Overtraining 
Syndrome (OTS) has been defined as prolonged fatigue and under-performance 
following periods of heavy training98. The plasma concentration of glutamine has been 
reported to be lower in overtrained athletes than in well trained athletes and sedentary 
individuals 73,84,101,116. Rowbottom et al. observed a lower mean plasma glutamine level 
in a group often athletes classified as overtrained (703 ~mollL) compared with sedentary 
(1030 ~mol/L) and athletic age-matched controls (1179 ~mol/L)116. While Parry-
Billings et al. reported mean plasma glutamine levels of 503 ~moliL in a group of 40 
athletes diagnosed as having the OTS, compared with a mean level of 550 ~mol/L in a 
group of controls101 . Plasma glutamate (the precursor to glutamine) levels were, 
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however, reported to be significantly higher (161 VS. 125 IlmollL) in the group suffering 
from the OTS. In another study, glutamine responses in trained cyclists who completed 
two weeks of intensified training were examined and while no significant changes in 
glutamine were noted across the two week period, a decline in the glutamine/glutamate 
ratio was found53. This relationship has also been noted by Smith and Norris who 
hypothesize that glutamine concentration decreases when the volume of work exceeds the 
athlete's capacity to tolerate work l2o. Various reasons have been suggested as the cause 
of the decline in glutamine concentration over time, such as increased levels of 
glucocortiocods6, 81; decreased nutritional intake ofprotein82; mitochondrial lesions 
within skeletal muscle 1 16; and increased rate of utilization of glutamine by other tissues 
rather than decreased productionl2o. 
Exercise and the Acid-Base Balance 
During high-intensity exercise, glycolytic energy production is elevated with a 
concomitant increase in lactate (La-) and hydrogen ion concentration (H+) within the 
working tissues58, 59, 74. Consequently, the accumulation of H+ results in a decrease in pH 
which is thought to (a) reduce force production through hindered excitation-contraction 
coupling34, 37, (b) inhibit glycolytic energy production25, 125,129, and (c) decrease cross-
bridge cycling87, 138. Therefore, it is believed that an artificially induced alkalosis 
(increase in pH) may enhance performance by improving the buffering capacity of the 
blood and tissues to withstand the decrease in pH associated with high-intensity 
. 86 exercIse . 
Past studies have demonstrated that an induced alkalosis (using sodium 
bicarbonate or sodium citrate) can delay the onset of fatigue by buffering the 
13 
accumulation of H+ and aiding the efflux of lactate from contracting tissues during high-
intensity exercise lasting between 30-seconds and 4-minutes I5, 18,27,90,92,93,103,125,144, In 
one study, six trained male athletes were studied under control, sodium bicarbonate 
(NaHC03) and placebo conditions to study the effect of induced alkalosis on 400-m 
racing time, In the alkalotic condition the subjects ran significantly faster (1.52-sec) than 
either the control or placebo conditions, In addition, the post-exercise pH, bicarbonate 
and base excess levels were all lower in the alkalotic condition than in the others45, Thus 
suggesting that NaHC03 can be used an ergogenic aid by facilitating the efflux ofH+ 
from the skeletal muscles, Moreover, several investigators have reported a decrease in 
perceived exertion I II, 126, Sodium citrate ingestion has also been found to improve 
anaerobic performance of l20-sec and 240-sec on a cycle ergometer by increasing 
bicarbonate concentrations and decreasing pH levels94, However, some would argue that 
the evidence for any ergogenic effect resulting from ingestion of alkanizers is equivocal. 
Several authors found no improvement in the performance of high-intensity exercise 
~ 11 ' h' , f' h d" d' b' b ) 69 72 78 Th 10 owmg t e mgestIOn 0 elt er so mm CItrate or so mm lcar onate ' " e 
variation in findings may partially be explained by differences in the dosages of 
alkalinizing agents and in the exercise intensity and duration II, 
Dietary Influences on Plasma Glutamine Concentration 
There is substantial evidence that dietary intake can influence plasma glutamine 
levels43, 49,89, 134, 148, Gleeson et al. investigated the relationship between carbohydrate 
(CHO) intake and plasma glutamine; subjects exercised twice for 60-minutes at 70% 
V02max: once after consumption of a normal diet and once after three days on either a 
high (75%) or low (4%) CHO diet. Exercise after the low CHO diet resulted in a lower 
14 
post-exercise plasma glutamine concentrations when compared with the high CHO diet43• 
This is most likely due to resting metabolic acidosis, which has been shown to occur with 
very low CHO diets89. Circulating acidosis leads to an increased uptake of glutamine by 
the kidneys for the purpose of buffering H+ and this reduces plasma levels of glutamine I 6. 
In addition, glutamine is used as a gluconeogenic precursor I 17 and gluconeogenesis 
increases when CHO availability is IOW I6• Similar results were discovered by Blanchard 
et al. who investigated the relationship between muscle glutamine, muscle glycogen, and 
plasma glutamine concentrations over three days of high-intensity exercise during which 
CHO intake varied. Mean plasma glutamine concentration was significantly higher 
during the 70% CHO exercise trial when compared to the 45% CHO trial. However, 
glycogen decreased by the same magnitude during both trials and there was no 
relationship between changes in plasma glutamine and changes in muscle glycogen 
concentration. Because neither muscle glycogen nor muscle glutamine concentrations 
differed between diets and exercise trials, the authors suggested that the lowered CHO 
and increased protein intake (40% higher than that on the high-CHO diet) may have 
increased removal of glutamine from the circulationl6. These results are in agreement 
with data of Zanker et aI., which showed that consumption of an 80% CHO meal before 
intense endurance exercise resulted in higher glutamine levels compared with fasting for 
14-hours before exercise l48 . Studies in rats also indicate that pre-exercise CHO 
availability is an important factor, since 24-hour fasted rats exhibited a much greater fall 
in plasma glutamine after 30-minutes swimming compared with the same exercise 
performed in the fed state26• In contrast, van Hall et al. reported that CHO 
supplementation prior to and during exercise had no effect on plasma glutamine 
15 
concentration during exercise and did not prevent the post-exercise decrease in plasma 
glutamine 132. 
Research has also shown that protein intake can influence plasma glutamine 
concentration, as increases of plasma glutamine levels of up to 29% were observed 
following meals21 especially those with substantial protein content. Alternatively, it has 
been demonstrated that a diet rich in protein (24% protein, 72% fat, 3% eRO) consumed 
for four days results in a 25% lowering of muscle and plasma glutamine levels50. 
Furthermore, in a study aimed at determining the relationship between resting plasma 
glutamine concentration and dietary protein intake for athletes of different sports 
(runners, swimmers, cyclists, nonathletes) dietary protein intake expressed relative to 
body mass (g·kg·l·d-l) was significantly inversely related to plasma glutamine 
concentration. This negative relationship may be explained by an increase in glutamine 
uptake in the kidney, in an attempt to maintain acid-base balance in athletes consuming a 
high protein diet61 • Ammonia produced via the hydrolysis of glutamine to glutamate 
binds to a hydrogen ion to form ammonium ion49,63, 117. In combination with an anion, 
commonly chloride, ammonium is excreted in urine. In this way, the kidney is able to 
effectively excrete excess protons, and thus prevent cell acidosis associated with a high 
protein diet 48,49. 
Diurnal Variations of Plasma Glutamine Concentration 
It is important to note that intra-individual plasma glutamine concentrations can 
vary widely during the dal l . During starvation or an overnight fast, the supply of 
glutamine from the intestinal lumen is reduced because the glutamine present in the 
protein of the diet is mainly metabolized by the absorptive cells of the small intestine. It 
16 
is believed that 50-60% of glutamine is utilized in this way40. Early studies shave 
identified a diurnal variation in plasma total amino acid level38, as well as a similar 
variation for individual amino acids, including glutamine39. Although dietary influences 
may have been a major contributor in these studies, diurnal changes have been reported 
in healthy young adults following an overnight fast99. More recently, it seems that 
studies examining possible diurnal variations in glutamine concentration have published 
conflicting results. Plasma glutamine levels were monitored for a period of 2 I-hours in 
four healthy volunteers (n = 4) with no dietary restrictions, which resulted in a plasma 
glutamine increase two-hours after ingesting a meal containing protein. Castell et al. 
reported that during a 2 I-hour fast there was almost no change in plasma glutamine levels 
throughout the day, compared with the normal day (free of dietary restrictions), thus 
suggesting the absence of diurnal variations. However, it should be noted that only one 
subject participated in the 2 I-hour fast within the stud; 1 • 
Glutamine Supplementation 
Antonio and Street state that it would seem plausible that glutamine 
supplementation may exert a beneficial effect for individuals engaged in chronic and 
intense exercise training. They believe that because glutamine concentrations decline in 
a dose-dependent manner 77, one could hypothesize that exercise training would increase 
the requirements for glutamine such as that exogenous self-administration may be 
necessary for ultimate performance and complete recovery4. Antonio and Street state 
their hypothetical reasoning for glutamine supplementation by athletes on established 
effects of exercise stress and glutamine. Since glutamine plays a crucial role in the 
functioning of the immune system and its' cells, it may be suggested that glutamine 
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supplementation may prevent or lessen severity of illness or infection after an intense 
bout of exercise, thus enabling the athlete to resume intense training more quickly. In 
addition, glutamine supplementation may offset catabolic effects of elevated 
glucocorticoid levels that are produced during exercise. Moreover, the provision of 
glutamine to fuel other organs (gastrointestinal tract, liver, kidney, and immune cells) 
could spare the potential loss of glutamine due to inadequate dietary intake, thus sparing 
muscle protein 4• 
Of particular importance is the theoretical effect glutamine may have on the acid-
base balance within the body by producing a buffering effect. It is suggested that 
glutamine alters the acid-base balance by increasing plasma bicarbonate (HC03) retention 
within the kidneys, via deamination, when glutamine enters the epithelial cells of the 
k 'd 139 142 147 Th . h' ~ d fr h d . . fl' 1 neys ' , . e ammomum t at IS lorme om t e eammatlOn 0 g utamme, 
then binds with a H+ to form an ammonium ion. This loss from the epithelial cell drives 
the carbonic anhydrase reaction to yield HC03 and H+. The excess intracellular HC03 
diffuses into the extracellular regions with a sodium ion and subsequently enters systemic 
circulation51 • The ammonium ion combines with an anion (usually chloride) and is then 
excreted in the urine97 , thus allowing the kidneys to effectively excrete excess protons 
and protect the body from acidosis46. More simply, once glutamine is oxidized in the 
Krebs cycle, it is transported into the kidneys to dispose of nitrogen and recycle the 
carbon skeleton. 
Although Ziegler et al. confirmed that acute oral glutamine ingestion did not show 
any signs of toxicity in patients receiving glutamine for several weeks l49, very few 
studies have investigated the effects of glutamine supplementation on athletic 
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performance and recovery from high-intensity exercise. One study performed by 
Antonio and colleagues3, aimed to determine if high-dose glutamine ingestion affected 
weightlifting performance. In a double blind, placebo-controlled, crossover study, six 
resistance trained men performed weightlifting exercises after ingestion of glutamine or 
glycine (0.3 g·kg body mass-I) mixed with calorie-free fruit juice or placebo. One hour 
after ingestion, subjects performed four total sets of exercise to momentary muscular 
failure. The findings indicated that short-term ingestion of glutamine does not enhance 
weightlifting performance in resistance-trained men. Antonio et al. further suggested that 
future work should examine long-term supplementation of glutamine in athletes during a 
competitive season3. 
In a similar study, Haub et al. 56 investigated the potential of glutamine 
supplementation to alter the acid-base balance of the blood and subsequently increase the 
time to exhaustion during high-intensity exercise. The researchers based their 
investigations on the theory that glutamine alters acid-base status by increasing HC03 
retention in the kidneys. Ten trained males performed five exercise bouts on a cycle 
ergometer at 100% V02peak. The first four bouts were 60-sec in duration, while the fifth 
bout was continued to fatigue. Each bout was separated by 60-seconds recovery. The 
exercise bouts were initiated 90-minutes after ingesting 0.03 g·kg body mass-I of either 
glutamine or placebo. Venous blood samples showed no significant difference in pH, 
[HC03], and lactate concentration ([La-]) between pre-ingestion, pre-exercise, bout four 
and bout five. In addition, time to fatigue was not significantly different between 
conditions. Overall, the data indicated that acute glutamine ingestion did not enhance 
either buffering potential or exercise performance in trained males. However, the 
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researchers suggest that the environment may need to be acidic in order to activate 
glutaminase (the enzyme responsible for the breakdown of glutamine in the kidney) and 
ultimately use glutamine to increase HC03
56
. 
In a recent study Piattoly investigated the effects of glutamine supplementation on 
recovery from intense exercise among elite cyclists. Specifically, the influence of 
glutamine supplementation (0.3 g·kg body mass·! for six days) on time to exhaustion and 
power after a prolonged bout of exercise was analyzed. The results showed no group 
differences in V02peak, peak power and time to exhaustion before supplementation, and 
participants in both the glutamine group and placebo group experienced similar declines 
in performance immediately and 24-hours after an exhaustive bout of exercise. However, 
it was discovered that participants in the glutamine group increased time to exhaustion 
following six days of supplementation and appeared to recover from exhaustive exercise 
earlier than those participants that did not ingest glutamine {placebo group)!04. 
In addition, data showing low plasma glutamine and an increased occurrence of 
upper respiratory tract infections in some groups of highly trained athletes has raised 
interest in glutamine supplementation for those investigating immune function during 
periods of intense training and post-exercise recovery137. One study specifically 
examined a possible prophylactic effect of oral glutamine supplementation on the 
occurrence of infection24. Castell et al. gave ultra-marathon and marathon runners 
participating in races either a placebo drink (malo-dextrin) or glutamine solution (5-
grams glutamine in 330mL of water) immediately upon completion and two-hours after 
the race. Athletes were given questionnaires to self-report the occurrence of symptoms of 
infection for seven days after the race. In those receiving the glutamine supplements (n = 
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72), 81 % experienced no infection in that period. In those receiving the placebo drink (n 
= 79), only 49% experienced no infection in the same period. The authors concluded that 
the provision of two glutamine drinks in the first two hours post-race decreased the 
incidence of infection in the week after the event24. Similarly, another study found that a 
glutamine solution (0.1 g'kg body mass-I) given at 0, 30, 60, and 90-min following a 
marathon race prevents the fall in plasma glutamine concentration 113. 
Glutamine Absorption 
In a glutamine supplementation study, Castell et al. found that after administering 
glutamine, plasma glutamine concentrations increased by at least 50%, peaking at 30-
minutes after ingestion and remaining elevated for one to two-hours before returning to 
the normal range of 500-700 JlmollL. Subjects were either given 0.1 or 5 grams L-
glutamine per kilogram of body weight22 . In another study Ziegler found similar results 
in whole blood. Rested subjects were given either 150-ml distilled water (zero glutamine 
dose), 150-ml water containing O.l-gram glutamine per kilogram of body weight (low 
glutamine dose) or 150-ml distilled water containing 0.3 g'kg body weight (high 
glutamine dose). Whole blood concentrations of glutamine rose in proportion to 
administered oral glutamine load. Blood glutamine levels peaked 30-45 minutes after 
ingestion and then decline steadily to the normal range within 90-120 minutes (low dose) 
or 180-240 minutes (high dose)149. 
Summary 
In summary, glutamine is an amino acid that is crucial for many important 
homeostatic functions and for the functioning of a number of tissues in the body. During 
various catabolic states including surgery, infection and acidosis, glutamine homeostasis 
is placed under stress and glutamine reserves can become depleted. Similar to a catabolic 
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stress, high-intensity exercise may result in an increase, decrease or no change in plasma 
glutamine levels during and after exercise. The resulting changes have been found to be 
dependent upon the type, duration and intensity of exercise. Based upon previous human 
research studies of glutamine supplementation, some researchers believe glutamine has a 
potential utility as a dietary supplement for athletes participating in high-intensity 
exercise. The mechanism behind this potential has been suggested to be due to 
glutamine's influence on the acid-base balance within the body. To date, only one study 
has reported an ergogenic effect (specifically, an increased time to exhaustion) due to 
glutamine supplementation, thus warranting additional research in this area in attempts to 
elucidate the equivocal data. 
The present study will add to the current literature by examining a comprehensive 
set of variables, which include plasma glutamine, glutamate, alanine and lactate 
concentrations before, during and after exercise. Of the three supplementation studies 
previously mentioned, the study conducted by Haub et al. was the only one to analyze 
any blood work throughout the testing protocol. Blood was analyzed for pH, La- and 
HC03 concentrations at baseline, pre-exercise (90-minuntes post-ingestion), and after the 
fourth and fifth bouts of exercise56 . The studies conducted by Antonio et al. and Piattolly 
et al. did not collect blood samples at any time throughout data collection3, 104. By 
collecting blood samples, we hope to gain a better understanding for how high-intensity 
exercise influences plasma glutamine, glutamate, alanine and lactate concentrations 
before, during and after exercise. In addition, we will be analyzing expired gases for 
V02max, C02 production, and respiratory exchange ratios, which have not been looked 
at in previous supplementation studies. We will also be utilizing a treadmill running 
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protocol, which is a novel exercise testing modality, as previous studies have only 
examined the effects of supplementation on weight lifting performance and cycling3, 56, 
\04. More specifically, our study will be utilizing an exercise protocol that should rely on 
a combination of aerobic and anaerobic pathways to produce energy as the protocol is 
designed to induce fatigue within 8-14 minutes. This is in contrast to the exercise 
protocols used in previous studies, which could be classified as purely anaerobic. Lastly, 
our study will be taking into account the average dietary intake of each subject, which 
despite recent literature demonstrating the influence high protein/low carbohydrate 
consumption on plasma glutamine concentration, has not been considered in any of the 





Seven healthy subjects (six males and one female) between the ages of 18 and 30 
participated in this study. The subjects participated in a minimum ofthirty minutes of 
moderate to high-intensity aerobic exercise at least four days a week and were free of 
metabolic, cardiovascular, and orthopedic limitations as determined through a self-
reported health survey (Appendix A) and participation questionnaire (Appendix B). 
Individuals taking supplements (e.g. creatine, amino acid) were excluded from the study. 
Prior to participation, subjects were informed of potential risks and benefits, familiarized 
with all testing procedures and asked to sign an informed consent (Appendix C) approved 
by the Institutional Review Board of the University of Louisville. The descriptive 
characteristics (mean ± SD) of the subjects were as follows: age (23.0 ± 1.0 yrs), height 
(173.1 ± 8.2 cm), weight (74.5 ± 13.3 kg), BMI (24.7 ± 3.0 kglm2), body fat percentage 
(12.7 ± 7.1 %), resting systolic blood pressure (112.5 ± 8.2 mmlHg), resting diastolic 
blood pressure (80.2 ± 6.4 mmlHg), and resting heart rate (72.2 ± 6.6 b·min- I ). 
Session 1 
Subjects participated in three sessions. During the orientation session (session 1), 
the research project and procedures were explained to the subject and consent was signed. 
In addition, the general health and overall body composition of the subject was assessed 
by obtaining each subject's height, weight, heart rate, blood pressure and skin fold 
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measurements. Subjects were instructed to maintain current levels of exercise and to not 
alter dietary habits for the duration of the study. Each subject was asked to complete and 
tum in a three-day food diary before the first day of exercise testing. The food diary 
included everything the subject consumed for three days (one weekend day and two week 
days). Instructions to complete a three-day food diary and food logs were provided for 
the subjects (Appendix D). Food diary data was then analyzed by Diet AnalysisTM 
software (Version 7.0). 
Session 1 Measurements 
1. Height & Weight 
Height was measured without shoes in centimeters. Weight was measured without 
shoes to the nearest 0.5 pound. 
2. Heart Rate 
Heart rate was measured via radial artery pulse palpation. The pulse was counted for 
15 seconds and then multiplied by four, to determine the per-minute heart rate. 
3. Resting Blood Pressure 
Resting blood pressure was measured with the subjects seated in a chair with their 
feet on the floor. 
4. Body composition 
Body composition was determined using a three-site skin fold measurement. Skin 
fold measurements were obtained at the chest, abdomen, and thigh for male subjects. 
Measurements were obtained at the tricep, suprailiac, and thigh for female subjects. 
Gender specific regression equations were then used to convert the sum of skin folds 
to percent body fat64 . 
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Sessions 2 & 3(Exercise Testing Sessions) 
Subjects then participated in two separate exercise testing sessions. Before the 
first exercise testing session (session two), all subjects were assigned to one of two 
treatment groups (Group A or Group B). Treatment order was randomly assigned and 
subjects were not informed as to which treatment group they had been assigned. Group 
A participated in the experimental (glutamine supplementation) condition during the 
second session and the control (placebo) condition during the third session. Group B 
participated in the control condition during the second session and the experimental 
condition during the third session. All subjects participated in both the experimental and 
control treatment, with a minimum of seven days between testing sessions. 
For each exercise testing session, subjects were asked to abstain from exercise 
and to fast (water only) for two-hours prior to reporting to the laboratory. Upon reporting 
to the laboratory for the exercise testing sessions, height, weight, resting blood pressure 
and heart rate were recorded. Next, a research registered nurse trained and credentialed 
in intravenous catheter (IV) placement, prepared the subject for the blood draws. The 
baseline blood sample was collected via an IV catheter that was inserted by the research 
nurse. The subject was then instructed to consume 0.03 g'kg body mass-I of either 
glutamine (Progressive Laboratories, Inc., Irving, TX) mixed with 250 ml of caffeine-free 
fruit juice or 250 ml of placebo matched for caloric input (caffeine-free fruit juice). All 
drinks were pre-mixed by a research assistant before the subject's arrival and to ensure 
compliance, subjects were asked to consume the drink under the supervision of 
laboratory personnel within ten-minutes. Once the assigned solution had been consumed 
subjects rested for one hour in a sitting position. 
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At the end of one hour, the research nurse obtained the second blood draw (60-
min post ingestion). Subjects then provided urine and saliva samples which were 
analyzed using a pH test strip (Sigma, St. Louis, MO). Next, the subjects performed a 
maximal exercise test on the treadmill and V02max was determined via indirect open 
circuit spirometry (ParvoMedics, Sandy, UT). The Bruce treadmill protocol consisted of 
incremental increases in workload and was designed to induce fatigue within 8-14 
minutes (Appendix E)2. Ratings of perceived exertion (RPE) were obtained every three-
minutes using the Borg's Category Scale17(Appendix F) and heart rate (Polar 610i HR 
Monitor, Polar Electro, Finland) was recorded every minute throughout the exercise test. 
Determination ofV02max was ascertained if the subject met two of the following 
criteria: 1) A plateau in oxygen uptake (or failure to increase oxygen uptake by 150 
mLimin) with increasing workload; 2) a respiratory exchange ratio (RER) 2:1.15; or 3) a 
RPE of> 17 on the Borg 6-20 scale6o. RER values are a ratio between the amount of 
carbon dioxide produced and the amount of oxygen consumed by the body 
(VC02/V02)20. In addition, the research nurse obtained blood samples every four-
minutes, resulting in a possible maximum of four separate blood draws (4-min exercise, 
8-min exercise, 12-min exercise, 16-min exercise) during exercise. The actual number of 
blood draws was unique to the subject and dependent upon the duration ofthe exercise 
test. 
Upon the completion of the exercise test, subjects immediately moved to a chair 
while remaining connected to the metabolic cart for 10-minutes. After, the initial 10-
minute recovery period subjects were disconnected from the cart and then reconnected 
for 5-minute intervals at 25-min and 55-min post exercise in order to obtain recovery data 
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at 30-and 60-min post exercise. During the one-hour recovery period, heart rate (Polar 
610i HR Monitor, Polar Electro, Finland) was recorded I-min post exercise, 3-min post 
exercise, 5-min post exercise, IO-min post exercise, 30-min post exercise and 60-min 
post exercise. An RPE value was also recorded upon completion of exercise. In 
addition, blood samples were obtained 5-min post-exercise, lO-min post-exercise, 30-min 
post-exercise and 60-min post exercise. At the commencement of the one-hour recovery 
period, subjects provided urine and saliva samples which were analyzed for pH values. 
Blood Draw Procedure: 
Blood samples were collected pre-exercise, during exercise and post-exercise 
testing. To collect multiple blood draws with minimal discomfort to the subject, an IV 
catheter was inserted by the research nurse. The following procedure was used: Subjects 
were asked to sit with either left or right arm resting on the table and a tourniquet was 
applied by the research nurse. The subject's forearm was reviewed for the optimal site to 
insert the IV. Once determined, the area was cleaned with an alcohol prep pad saturated 
with 70% isopropyl alcohol. Depending on the subject's veins, either an 18-gauge or 20-
gauge IV catheter (Becton Dickinson, Sandy, UT) was inserted. An IV catheter 
extension set (Baxter Health Care Corporation, Deerfield, IL) was connected to the end 
of the IV and blood work was drawn using a 5-mL syringe. Once drawn, the IV was 
flushed with 5-mL of 0.9% sodium chloride (saline solution) in order to maintain patency 
and ensure there was no discomfort or adverse effects to the IV placement. Surgical tape 
was used to secure the catheter to the subject's arm. The blood was then transferred into 
a vacutainer blood collection tube with sodium fluoride potassium oxalate (5mg/4mg) 
(BD Vacutainer®, Franklin Lakes, NJ). Blood was collected intermittently throughout 
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each exercise testing session, resulting in a possible maximum often separate blood 
draws (baseline, 60-min post ingestion, 4-min into exercise test, 8-min into exercise test, 
12-min into exercise test, 16-min into exercise test, 5-min post exercise, 10-min post 
exercise, 30-min post exercise, and 60-min post exercise) and no more than 80-ml of 
blood was obtained from a subject during each exercise testing session. Following the 
initial blood draw, each subsequent blood draw began with drawing 3-ml of 'waste' fluid 
(saline flush and blood) from the IV using a 5-mL syringe. This was followed by a 
second syringe being used to withdraw approximately 5-ml of blood from the catheter 
which was then transferred into a vacutainer blood collection tube with sodium fluoride 
potassium oxalate (5mg/4mg). The IV was flushed with 5-mL saline solution to ensure 
patency for future blood draws. The blood samples were given time to clot and then 
centrifuged (Smith Kline Beechman Clinical Laboratories, Model 6500) at 3400 rpm for 
approximately 20 minutes in order to separate the serum from the cellular components. 
Serum was then pipette transferred into a micro centrifuge tube (Fischer Scientific, 
Pittsburgh, P A) and stored at -80°C until ready for analysis. If during exercise, the 
research nurse was unable to obtain a sufficient (3-mL) amount of 'waste fluid' and/or 
blood, the sample was not obtained. If post-exercise, the research nurse was unable to 
obtain a sufficient (3-mL) amount of 'waste fluid' and/or blood, the sample was collected 
via venipuncture. A different venous site was used to draw blood using a 21-gauge 
"butterfly needle" (Becton Dickinson, Franklin Lakes, NJ) and transferred into the 
vacutainer blood collection tube with sodium fluoride potassium oxalate (5mg/4mg). The 
"butterfly needle" was inserted after the site was cleaned with an alcohol prep pas 
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saturated with 70% isopropyl alcohol and was immediately removed after collecting the 
blood sample. 
Statistical Analyses 
SPSS (Version 16.0) was used for all statistical analyses with significance set at 
p<O.OS. Basic descriptive statistics were calculated for all data and values are reported as 
mean ± standard deviation. Dependent t tests were performed to assess differences 
between means for the experimental (glutamine) and control (placebo) trials and are 





No significant difference was observed between treatments for V02max or post-
exercise oxygen consumption at any measurement time during recovery (Table 2). 
CO2 Production 
No significant difference was found between treatments for CO2 production 
(Table 3). Carbon dioxide values were recorded every 15-seconds during exercise, 
however the values used for analyses were derived from an average of the second and 
third minute of each completed stage of the protocol to ensure values represented a 
physiological steady state. Since only one subject was able to complete Stage 5, only 
stages 1 through 4 were included in the analyses. Post-exercise C02 production values 
were not significantly different between treatments at any measurement time during 
recovery. 
Respiratory Exchange Ratio 
Maximum respiratory exchange ratios (RER) during exercise and post-exercise 
values are displayed in Table 4 for the seven subjects (six males and one female). No 
significant treatment effect was observed for the maximum RER value during exercise, 
nor for values at lO-min post, 30-min post and 60-min post-exercise. Significance was 
observed between treatments for the RER value at 5-min post exercise, with the GLN 
trial producing a higher RER value than the PLC trial (p = 0.042). 
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Heart Rate 
Heart rate responses during exercise and post-exercise are shown in Table 5. No 
significant treatment effect was observed for heart rate during exercise or at any 
measurement time post-exercise. Similarly, there was no significant difference observed 
between treatments for heart rate immediately upon the completion of exercise. 
Ratings of Perceived Exertion 
Ratings of perceived exertion (RPE) responses can be found in Table 6. No 
significant treatment effect was found for RPE at any time measurement during exercise 
or immediately upon completion of exercise. 
Urine & Saliva pH 
The pH values for both urine and saliva pre- and post-exercise can be found in 
Table 7. There was no significant difference between the two treatments. 
3-Day Dietary Intake 
Three-day dietary averages can be seen in Table 8 for the seven subjects (six 
males and one female). Each subject's food diary was analyzed for 1) average intake of 
carbohydrates, proteins, and fats (in kcal and percentage of total intake); 2) average daily 
dietary intake in kcal; and 3) average intake of carbohydrates, proteins, and fats in grams. 
Blood Analysis 
All results pertaining to serum glutamine, glutamate, alanine and lactate 
concentrations are currently pending analysis. 
Gender Differences 
When the one female subject was removed from all statistical analysis, 
significance was no longer observed at 5-min post-exercise for RER. Similarly, no 
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significant differences in 02 consumption, C02 production, RER, HR, RPE, and urine pH 
were found between treatments at any measurement time (Tables 10-15). The pH values 
for saliva pre- and post-exercise can be found in Table 15. No significant treatment 
effect was observed for saliva pH pre-exercise, however, significance was observed 
between treatments for post-exercise saliva pH, with the GLN trial producing a higher pH 
than the PLC trial (p=0.025). Lastly, the three-day dietary averages for male subjects can 
be found in Table 16. 
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Table 1. Plasma ~lutamine concentration followin~ exercise in humans 
Reference Study EX Methodology Changes in 





Continuous or intermittent high-intensity EX 




Sewell et 9 RM (2F) 60 sec treadmill Enzymatic (G) i5 Return to 
al.I 19 running at 20 kmIh baseline 
at 5min 
20 kmIh treadmill after 
run to exhaustion j14 
Robson et 18 TM Cycling to Enzymatic (G) 13 i2 at 5h 
al. 112 exhaustion at 80% 
V02max 
Katz et al. 68 8RAM Cycling to HPLC i26 i13 at 
exhaustion at 100% 10min 
V02max 
van Hall et 8TM 3 min cycling at Enzymatic (-) 19 116 at 2h 
al.132 50% W max and 6 
min at 80% W max 
alternated to 
exhaustion 
van der 8TM 2 min cycling at Enzymatic (-) 120 124 at2h 
Schoor et 90% Wmax 
al. 131 alternated with 2 
min at 50% W max 
until exhaustion 
Keast et 7TM 15 x 1 min Bioassay 144 
a1. 7O treadmill exercise 
at 90% V02max 
15 x 1 min 155 
treadmill exercise 
at 120% V02max 
Walsh et 8TM 20 x 1 min cycling Enzymatic (G) 12 116 at 5h 
al. 136 at 100% V02max 
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Table 1 (cont.) 
Prolonged light-moderate intensity EX 
Parry- 22 T (20 M) Marathon;:::: 150 Enzymatic (A) 116 
Billings et 12 TM min 
al. lol 4TM 
30 km self-paced i8 
treadmill run 
Cycling to i8 
exhaustion ay 73% 
V02max 
Rennie et 4RAM 3.75h cycling at HPLC 116 130 at 
I 110 50% V02max 2h a. 
Babij et al. IU 8RAM 10 min incremental Column i28 Return 
cycling at 25, 50, chromatograph to 
and 75% V02max y baseline 
and to exhaustion at 
IOmin 
Eriksson et II RAM 45 min incremental HPLC 124 il2 at 
al.36 cycling to 75% Ih 
V02max 
Robson et 18 TM Cycling at 55% Enzymatic (G) 111 123 at 
al. ll2 V02max for 180 Ih 
min 
Maughan & 5RAM 90min cycling at Enzymatic (G) 13 
Gleeson et 70% V02max 
al. 88 
Decombaz 8TM 100 km run Column 116 1 at 24h 
et ae l chromatograph 
y 
Rohde et 8TM 2500m swim, HPLC 120 132 at 
I 114 a. 81km cycle, 19km 2h 
run 
a = percentage difference from pre-exercise plasma glutamine level (not corrected for 
plasma volume changes); A = asparaginase used to determine plasma glutamine; F = 
female; G = glutamine; HPLC = high performance liquid chromatography; M = male; 
RA = recreationally active but not specifically endurance trained; T = trained; W max = 
maximal work rate attained during an incremental exercise test; i = increased; 1 = 
decreased; EX = exercise 
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Table 2. V02 (ml/kg/min-l) during and post-exercise (mean ± SD) 
GLN PLe p-value 
V02max 61.5 ± 11.8 58.6 ± 10.1 0.065 
5-minPV02 8.82 ± 1.73 9.12 ± 2.31 0.412 
10-minPV02 7.61 ± 2.08 7.24 ± 1.00 0.414 
30-minPV02 6.56 ± 2.37 6.05 ± 1.46 0.399 
60-minPV02 4.94 ± 0.79 4.62 ± 1.09 0.557 
V02 = volume of oxygen consumption; P = post-exercise. n = 7 (6 males and 1 female), 
except for 30-minPV02 (n = 6; 5 males and 1 female). 
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Table 3. C02 Production (L/min) during and post-exercise (mean ± SD) 
GLN PLC p-va1ue 
Stage 1 1.18 ± 0.27 1.14±0.18 0.581 
Stage 2 1.77 ± 0.34 1.66 ± 0.32 0.362 
Stage 3 2.93 ± 0.53 2.55 ± 0.57 0.167 
Stage 4 4.37 ± 0.78 4.15 ± 0.65 0.483 
5-minP 0.79±O.l8 0.76 ± 0.24 0.366 
10-minP 0.53 ± 0.23 0.47 ± 0.12 0.237 
30-minP 0.33 ± 0.16 0.31 ± 0.09 0.447 
60-minP 0.27 ± 0.05 0.26 ± 0.03 0.613 
Stage 1 = average of minutes 2-3; Stage 2 = average of minutes 5-6; Stage 3 = average of 
minutes 8-9; Stage 4 = average of minutes 11-12; P = post-exercise. n = 7 (6 males and 1 
female), except for 30-minP (n = 6; 5 males and 1 female). 
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Table 4. Respiratory Exchange Ratio during and post-exercise (mean ± SD) 
GLN PLe p-value 
Max 1.13±0.04 1.13±0.07 0.944 
5-minP* 1.20 ± 0.07 1.11 ± 0.09 0.042* 
10-minP 0.91 ± 0.08 0.87 ± 0.08 0.122 
30-minP 0.70 ± 0.08 0.72 ± 0.09 0.564 
60-minP 0.73±0.10 0.76 ± 0.10 0.688 
Max = maximal RER during exercise; P = post-exercise, n = 7 (6 males and 1 female), 
except for 30-minP and 60-minP (n = 6; 5 males and 1 female), *p<0.05, significant 
difference between treatments. 
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Table 5. Heart Rate (b'min-l ) during and post-exercise (mean ± SD) 
GLN PLe p-value 
3-minE 110.1 ± 11.8 103.0± 16.4 0.379 
6-minE 132.7 ± 13.4 127.4 ± 16.5 0.109 
9-minE 158.8 ± 14.8 154.5 ± 16.8 0.462 
12-minE 182.0 ± 8.54 172.6 ± 23.1 0.403 
End 180.5 ± 8.26 181.8±5.81 0.579 
1-minP 132.6 ± 12.7 132.3 ± 20.0 0.962 
3-minP 113.1 ± 11.3 112.6 ± 10.3 0.875 
5-minP 107.0 ± 8.30 107.0 ± 8.40 1.000 
10-minP 104.1 ± 9.83 105.0± 10.8 0.773 
30-minP 96.8 ± 11.9 92.2± 15.4 0.255 
60-minP 82.8 ± 17.4 81.8±14.5 0.705 
E = during exercise; End = upon completion of exercise; P = post-exercise, n = 7 (6 
males and 1 female), except for 12-minE (n = 3 males), End (n = 6; 5 males and 1 
female), 1-minP (n = 6; 5 males and 1 female), and 3-minP (n = 6; 5 males and 1 female). 
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Table 6. Ratings of Perceived Exertion (mean ± SD) 
GLN PLe p-value 
3-minE 6.71 ± 0.75 6.57 ± 0.53 0.604 
6-minE 8.86 ± 1.34 8.57 ± 1.71 0.654 
9-minE 12.0 ± 1.73 11.5 ± 2.14 0.407 
12-minE 15.2 ± 0.95 15.0 ± 3.26 0.854 
End 18.0 ± 1.52 17.1 ± 1.86 0.356 
E = during exercise; End = upon completion of exercise, n = 7 (6 males and 1 female), 
except for 12-minE (n = 4 males). 
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6.67 ± 0.S6 
6.11 ± 0.19 
6.74 ± 0.S2 
6.91 ± 0.41 
PLC 
6.S0 ± 0.38 
6.14 ± 0.37 
6.77 ± 0.44 






Pre = I-hour post-ingestion, immediately pre-exercise; Post = I-hour post exercise; n = 7 
(6 males and 1 female). 
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n = 7 (6 males and 1 female) 
Mean± SD 
3296.0 ± 1113.4 
1657.1 ± 593.3 
581.7 ± 162.7 
931.2 ± 376.0 
50.5 ± 6.7 
17.7±3.9 
28.1 ± 5.6 
431.2± 166.7 
145.4 ± 40.6 
113.9 ± 60.5 
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Table 9. Descriptive characteristics of male subjects (mean ± SD) 
Mean±SD 
Age (yrs) 23.1 ± 0.98 
Height (cm) 175.6 ± 5.2 
Weight (kg) 76.5 ± 13.4 
BMI (kg/m2) 24.6 ± 3.3 
BF(%) 10.6 ± 5.0 
RSBP (mrnlHg) 113.0 ± 8.9 
RDBP (mrnlHg) 80.6 ± 7.0 
RHR (b'min-I ) 73.3 ± 6.6 
BMI = body mass index; BF = percentage of body fat; RSBP = resting systolic blood 
pressure; RDBP = resting diastolic blood pressure; RHR = resting heart rate; n = 6. 
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Table 10. V02 (mlIkglmin-1) during and post-exercise for male subjects (mean ± SD) 
GLN PLC p-value 
V02max 62.3 ± 12.7 59.4 ± 10.9 0.109 
5-minPV02 9.21 ± 1.53 9.60 ± 2.13 0.371 
10-minPV02 8.08 ± 1.83 7.50 ± 0.80 0.237 
30-minPV02 6.90 ± 2.49 6.36 ± 1.40 0.475 
60-minPV02 4.86 ± 0.83 4.66 ± 1.19 0.745 
V02 = volume of oxygen consumption; P = post-exercise, n = 6, except for 30-minP 
(n=5) 
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Table 1l.C02 Production (L/min) during and post-exercise for male subjects (mean 
±SD) 
GLN PLC p-va1ue 
Stage 1 1.24 ± 0.25 1.18±0.15 0.553 
Stage 2 1.84 ± 0.32 1.71 ± 0.32 0.401 
Stage 3 3.02 ± 0.53 2.59 ± 0.62 0.195 
Stage 4 4.48 ± 0.79 4.25 ± 0.65 0.547 
5-minP 0.83 ± 0.16 0.80 ± 0.23 0.554 
lO-minP 0.57 ± 0.23 0.49 ± 0.12 0.l44 
30-minP 0.35 ± 0.18 0.32 ± 0.09 0.489 
60-minP 0.27 ± 0.05 0.27 ± 0.03 0.937 
Stage 1 = average of minutes 2-3; Stage 2 = average of minutes 5-6; Stage 3 = average of 
minutes 8-9; Stage 4 = average of minutes 11-12; P = post-exercise, n =6, except for 
30minP (n=5) 
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Table 12. Respiratory Exchange Ratio during and post-exercise for male subjects 
(mean ± SD) 
GLN PLe p-value 
Max 1.13 ± 0.04 1.13±0.08 0.945 
5-min 1.18±0.04 1.10 ± 0.09 0.102 
lO-minP 0.91 ± 0.08 0.85 ± 0.08 0.106 
30-minP 0.69 ± 0.09 0.71 ±0.10 0.619 
60-minP 0.73±0.10 0.79 ± 0.12 0.363 
Max = maximal RER during exercise; P = post-exercise, n = 6, except for 30-minP (n = 
5). 
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Table 130 Heart Rate (bomin-I) during and post-exercise for male subjects (mean ± 
SD) 
GLN PLC p-value 
3-minE 108.1 ± 11.6 108.1 ± 10.0 1.00 
6-minE 130.1 ± 12.7 124.0 ± 15.1 1.08 
9-minE 156.5 ± 14.7 152.5 ± 17.4 0.562 
12-minE 182.0 ± 8.54 172.6 ± 23.1 0.403 
End 179.6 ± 8.90 181.8 ± 6.49 0.435 
I-minP 135.8 ± 1l.3 132.6 ± 22.4 0.690 
3-minP 114.0 ± 12.4 112.6 ± 11.6 0.713 
5-minP 107.1 ± 9.08 107.1 ± 9.19 1.00 
lO-minP 103.5 ± 10.6 104.3 ± 11.7 0.814 
30-minP 95.6 ± 12.6 91.5 ± 16.7 0.374 
60-minP 84.1 ± 18.7 83.3 ± 15.3 0.790 
E = during exercise; End = upon completion of exercise; P = post-exercise, n = 6, except 
for 12-minE (n = 3), End (n = 5), I-minP (n = 5), and 3-minP (n = 5). 
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Table 14. Ratings of Perceived Exertion for male subjects (mean ± SD) 
GLN PLC p-value 
3-minE 6.67 ± 0.81 6.50 ± 0.54 0.611 
6-minE 8.67 ± 1.36 8.33 ± 1.75 0.661 
9-minE 11.8 ± 1.83 11.3 ± 2.25 0.415 
12-minE 15.2 ± 0.95 15.0 ± 3.26 0.854 
End 18.7 ± 1.6 17.0 ± 2.00 0.272 
E = during exercise; End = upon completion of exercise, n = 6, except for 12-minE (n = 
4) 
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6.61 ± 0.59 
6.13 ± 0.20 
6.86 ± 0.45 
7.00 ± 0.37 
PLe 
6.51 ±0.41 
6.16 ± 0.40 
6.90 ± 0.30 






Pre = I-hour post-ingestion, immediately pre-exercise; Post = I-hour post exercise; n = 6. 
*p < 0.05, significant difference between treatments 
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Table 16. Average Dietary Intake from the Three-Day Food Diary for male subjects 
(mean ± SD) 
Male 
Total (kca1) 3545.8 ± 981.5 
Carbohydrate (kca1) 1764.5 ± 570.7 
Protein (kca1) 632.0 ± 102.5 
Fat (kca1) 1024.1 ± 311.7 
Carbohydrate % 49.8 ± 7.02 
Protein % 18.0 ± 4.19 
Fat % 29.3 ± 5.08 
Carbohydrate (grams) 460.1 ± 162.4 
Protein (grams) 158.0 ± 25.6 





The aim of this study was to examine the effects of glutamine supplementation on 
high-intensity exercise and recovery from exercise. More specifically, the primary 
purpose was to determine if acute glutamine supplementation improved performance 
during a high-intensity running bout on a treadmill by altering the acid-base balance 
(buffering capacity) of the blood. No significant difference in V02max, HR, or RPE was 
detected between the GLN and PLC trials. A secondary purpose was to determine if 
glutamine supplementation improved recovery parameters one-hour post exercise. No 
significant difference in HR, C02 production or RER was observed between trials. Thus, 
results of this study demonstrated no significant difference in maximal treadmill running 
performance or recovery between GLN and PLC treatments following acute glutamine 
supplementation. Unfortunately, due to the pending analysis of all blood work, it is not 
possible at this time to address the effects of high-intensity running on plasma glutamine, 
alanine, glutamate and lactate concentrations during and post-exercise and consequently, 
how acute glutamine supplementation mayor may not influence these parameters. 
In this study, the only significant difference observed between the GLN and PLC 
treatments when both male and female subjects were included in analysis, occurred 
within the RER values at 5-min post exercise (p = 0.042). The GLN trial (1.20 ± 0.07) 
produced a higher RER value than the PLC trial (1.11 ± 0.09), which indicates at 5-min 
post-exercise subjects were producing greater amounts of C02 relative to the amount of 
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02 consumed during the GLN treatment. During recovery from high-intensity exercise, it 
is common that RER values increase due to the rise in lactic acid which consequently 
gives rise to C02. CO2 is then eliminated from the body via the lungs, as the lactic acid 
in the blood is buffered by forming H2C03. Although it would seem logical to contribute 
the higher value in the GLN trial to an increased buffering capacity due to the 
supplementation of glutamine, because this was the only RER value to show significance, 
future research is warranted in this area. 
No significant differences in oxygen consumption were observed between 
treatments at maximal efforts during exercise or at any time throughout the one-hour 
recovery period. However it should be noted that the difference between V02max (61.5 
± 11.8 and 58.6 ± 10.1 mllkglmin for the experimental and control treatments, 
respectively) was approaching significance at p = 0.065. Although this fails to meet the 
established criterion for statistical significance (p < 0.05), it suggests that the subjects 
tended to use less oxygen at maximal intensity during the GLN treatment. In addition, no 
significant differences in heart rate, ratings of perceived exertion, C02 production, urine 
and saliva pH were found between treatments. 
The nutrient analysis from the three-day food diary for the six males and one 
female showed that the subjects' average intake consisted of a diet that was 50.5 ± 6.7% 
carbohydrate, 17.7 ± 3.9% protein and 28.1 ± 5.6% fat. Their average carbohydrate, 
protein and fat intake were 1657.1 ± 593.3kcal, 581.7 ± 162.7 kcal, and 931.2 ±376.0 
kcal, respectively, resulting in a total caloric intake of 3296.0 ± 1113.4 kcal. These 
values indicate that on average the subjects consume what is considered a 'balanced' diet 
for people who live an active lifestyle. According to the 2005 U.S. Department of 
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Agriculture's "Dietary Guidelines for Americans", acceptable macronutrient distribution 
ranges (AMDR) are 45-65% carbohydrate, 20-35% fat and 10-35% proteinl3O, The 
subjects in this study displayed values that were within these recommendations, hence the 
dietary habits of the subjects in the present study should not have influenced plasma 
glutamine concentration before, during or post-exercise, as past studies43, 49,89,134,148 have 
only demonstrated that high protein/low carbohydrate and high carbohydrate/low protein 
diets alter plasma glutamine concentration" However, at this point in time, we can only 
speculate due to the pending blood analysis, 
To our knowledge, no other studies have examined the effects of acute glutamine 
supplementation on performance and recovery from a high-intensity running bout. This 
study indicates that acute glutamine supplementation does not improve high-intensity 
exercise performance or recovery of this type, The comprehensive lack of significant 
differences between treatments could be contributed to numerous factors and without the 
blood analyses it is difficult to determine the mechanism(s) supporting the performance 
and recovery results, 
High-intensity exercise brings about dramatic alterations in acid-base status of 
intracellular and extracellular regions of working tissues56, Previous work has 
demonstrated that increasing the buffering capacity and pH of extracellular fluid and 
bl d ' ~ d ' h' h' , , 27 45 74 79 107 In dd't' 00 Improves perlormance unng Ig -mtensltyexerclse ' , , , , a lIOn, 
research indicates that L-glutamine has potential alkalinizing properties which may elicit 
improvements in exercise performancel39, 142, Welbourne demonstrated that the oral 
ingestion of 2-grams of glutamine significantly increased plasma bicarbonate (He03) 
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concentration in nonnal, healthy subjects, thus indicating the use for glutamine as an 
ergogenic aid139• However, the results of this study do not support this theory. 
It may be plausible that the administered dosage of glutamine (0.03 g·kg body 
mass-I) one-hour prior to exercise may not have been a great enough dosage to increase 
plasma glutamine concentrations. Castell et al. found that after orally administering 0.1 
g·kg body mass-lor 5-grams glutamine, plasma glutamine concentrations increased by at 
least 50%, peaking at 30-minutes after ingestion and remaining elevated for one to two 
hours before returning to the nonnal range of 500-700 llmollL22. This is three times the 
amount of glutamine administered in the current study. If there was not an increase in 
plasma glutamine concentration post-ingestion, then the subsequent increase in plasma 
HC03 concentrationl39 may not have occurred. However, in a study by Antonio et a1.3, 
similar perfonnance results were discovered despite to use of dosage ten times greater 
than that used in the current study. Subjects were given 0.3 g'kg body mass-lone-hour 
prior to perfonning four total sets of exercise to momentary muscular fatigue, yet no 
ergogenic benefit was shown3. More similar to our study, Haub et al. 56 gave 0.03 g·kg 
body mass-I, and 90-minutes after ingestion, subjects perfonned four bouts of 60 seconds 
cycling at 100% V02 peak followed by a fifth bout to exhaustion. There was no 
difference in perfonnance in the fifth bout between glutamine and placebo groups. It 
should be noted that plasma glutamine and bicarbonate concentrations were not measured 
in either of these supplementation studies56, 139. Since we did not investigate the changes 
in plasma HC03 concentrations and do not currently know how plasma glutamine 
concentrations responded to the study, it is impossible to detennine if this is an influential 
factor at this point in time. There is also the possibility that an increase in HC03 may not 
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have occurred because glutaminase, the enzyme responsible for the breakdown of 
glutamine in the kidney to initiate HC03 production, was not in a highly active statel43. 
Furthennore, for glutamine to elevate HC03 the physiological environment may have to 
be acidic. It has been demonstrated that endogenous L-glutamine shifts from a 
component for purine and pyramidine fonnation to one of base fonnation in the kidney 
during a state of metabolic acidosis lOl , 143. This supports the rationale that the 
environment may need to be acidic in order to activate glutaminase and subsequently use 
glutamine to increase plasma HC03
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. In this study, subjects were not in a state of 
metabolic acidosis prior to glutamine supplementation. 
Gender Differences 
Due to the fact that there was only one female in this study in comparison to six 
males, we thought it was important to examine the results controlling for gender. As 
previously stated, when the female subject was removed (n=6), no significant difference 
between the two treatments was observed for 02 consumption, C02 production, RER, 
RPE, HR, or urine pH. A significant treatment effect (p=0.025) was shown in the post-
exercise saliva pH, with the GLN trial producing a higher (more alkaline) value of7.00 ± 
0.37 compared to a more acidic value of 6.80 ± 0.36 in the PLC trial. It is logical to 
assume the more alkaline value in the GLN treatment may be due to the acute 
supplementation of a potential alkanizing agent (glutamine) prior to exercise, yet more 
research is needed to make a conclusive observation. 
As expected, the dietary intake averages changed drastically when the female was 
removed. The males' average intake consisted of a diet that was 49.8 ± 7.02% 
carbohydrate, 18.0 ± 4.l9% protein and 29.3 ± 5.08% fat. Their average carbohydrate, 
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protein and fat intake were 1764.5 ± 570.7 kcal, 632.0 ± 102.5 kcal and 10241.1 ± 311.7 
kcal, respectively, resulting in a total caloric intake of3545.8 ± 981.5 kcal. Despite the 
increase in total kcal, the male subjects still displayed values that met the AMDR's, thus 
plasma glutamine concentrations should not have been influenced 130. To our knowledge 
the literature has not suggested a gender difference in glutamine metabolism. However, 
it seems plausible that dietary intake may influence glutamine metabolism and ultimately 
plasma glutamine concentration as differences in fuel substrate utilization between males 
and females have been observed during exercise. For a given relative work intensity, free 
fatty acids compromise a greater proportion of the source of energy in woman than in 
men, thus resulting in greater lipid utilization41 , 127, 128. It appears that there is a 
connection between estrogen and increased lipid mobilization, such as estrogen's ability 
to inhibit lipoprotein lipase (responsible for the breakdown oftriglycerides in the blood 
stream for storage or fuel) or enhance epinephrine production, since a higher 
concentration of epinephrine increases the activity of hormone sensitive lipase 
(responsible for adipose tissue lipolysis)8. It has also been shown that muscle glycogen 
(storage form of carbohydrate that is located within the muscle cell) depletion is 25% 
greater in males compared with females when subjects were matched for training status 
and performance 127 • This is in agreement with females having a greater reliance on fats 
as fuel during exercise. 
Limitations 
The most obvious limitation to this study was the lack of blood analysis and 
hence, plasma glutamine, glutamate, alanine and lactate measurements. Without these 
measurements it was very difficult to assess the effectiveness of glutamine as an 
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ergogenic aid based upon a theoretical buffering capacity. Another limitation to this 
study was the small sample size (n = 7; n = 6, when female excluded) to detect 
differences between the GLN and PLC treatment. Power and sample size analyses for 
each variable for n = 7 and n = 6 (males only) can be found in Appendix G. The exercise 
protocol is another potential limitation because previous studies used different modalities 
(strength training and cycling), durations, and intensities of exercise to examine the 
effects of glutamine supplementation3, 56, 104 which makes it difficult to compare results. 
Furthermore, the blood draw procedure used during testing proved to be problematic as it 
was often difficult to obtain the desired amount to blood from the subject, especially 
during exercise. This is most likely due to the fact that during exercise, blood is 
redirected away from areas were it is not needed (i.e. forearms) and to the working 
muscles. Lastly, the lack of diet logs prior to reporting to the lab on testing days could 
have been another possible limitation, as subjects were not asked to report what they 
consumed on exercise testing days. Although, all subjects reported to the lab after a two-
hour fast, it might have been beneficial to use a control meal to exclude the possibility of 
a high-proteinllow-carbohydrate or high-carbohydrate/low-protein meal influencing 
plasma glutamine concentrations. 
Future Research 
The findings from our research suggest that other research could be conducted to 
better understand the effects of acute glutamine supplementation on high intensity 
exercise and recovery from exercise. Future studies should examine the changes that 
occur during and post-exercise to plasma glutamine, glutamate, alanine, HC03, pH and 
lactate values. Studies should also examine the effects of acute supplementation at 
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various dosages on perfonnance and recovery parameters, such as V02max, RER, C02 
production, heart rate, and ratings of perceived exertion. Research is also warranted in 
the area of long-tenn glutamine supplementation for athletes participating in numerous 
high-intensity perfonnances separated by only a few hours, as supplementation may 
allow for a more favorable acid-base status prior to subsequent perfonnances. 
Summary 
In summary, this study demonstrated no significant difference in maximal 
treadmill running perfonnance between GLN and PLC treatments following acute 
glutamine supplementation. Although, there was a significant difference in the 5-min 
post-exercise RER value this was due to the inclusion of the female in the group analysis. 
More research is needed to make a conclusive observation about the effects of acute 
glutamine supplementation on recovery from high-intensity exercise. Therefore, the 
potential of acute glutamine supplementation as an ergogenic aid due to an increased 
buffering capacity has yet to be observed. 
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APPENDIX A 
THE UNIVERSITY OF LOUISVILLE 
EXERCISE PHYSIOLOGY LABORATORIES 
Health Survey 
Name ______________ Local Phone _________ _ 
Local Address, __________________________ _ 
Today's Date _______ _ Birth date _______ _ 
Age ____ _ Sex ___ _ Weight ___ Height ___ _ 
1. Have you ever been diagnosed as having any of the fol/owing (if there is a family history 
of any of the fol/owing, please check the Family History column)? 
Never In Past Presently Family History 
a. Heart Diseases 
b. Rheumatic Fever 
c. High Blood Pressure 
d. Hemophilia 
e. Other Vascular Disorders 
f. Diabetes 
g. Kidney Disease 
h. Liver Disease 
i. Asthma 
j. Allergies (in general) 
k. Chronic Bronchitis 
1. Other Respiratory Illness 
m. High Serum Lipids 
n. Anemia 
o. Low Blood Sugar 
p. Neuro-Musculo-Skeletal Problems 
2. Please indicate any surgery that you have undergone and the approximate date(s): 
3. Please indicate recent illnesses or major injuries that you have had & the approximate 
date(s): 
4. Please list any and aI/ medications that you are presently taking: 
Medication Dosage Dosage per day 
5. Do you smoke? ___ _ Packs per day 
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6. Describe your present training program (the activity, amount per day, days per week, and 
the length of time you have been training at this level): 
Activity Minutes/Day Days/Week Weeks of Training 




Subject Participation Questionnaire 
1. Name ________________ _ 
2. Please describe in detail your current exercise program. Please specify the 
activity, amount per day, days per week, and the length oftime you have been 
training at this level 
3. Have you recently experienced an illness or injury that has required you to take 
time off from training? If yes, please explain. 
4. Have you previously taken dietary supplements (protein powder, creatine, amino 
acids, etc.)? If yes, please specify. 
5. Are you currently taking dietary supplements? If yes, please specify. 
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APPENDIXC 
Subject Informed Consent 
ritle of the research study: The effects of glutamine supplementation on maximal 
perfonnance and recovery from high-intensity exercise. 
IRE assigned number: 07.0174 
Investigator(s) name & address: Jacks, Dean, Department of Health & Sport Sciences 
University of Louisville Crawford Gym, Room 114 Louisville, Kentucky 40292 
Site(s) where study is to be conducted: Belknap Campus Laboratory, Laboratory 
Phone number for subjects to callfor questions: Dean Jacks, Ph.D. at (502) 852-8352. 
Introduction and Background Information 
You are invited to take part this research study because you are 18-30 years of age and 
participate in thirty minutes of moderate to high-intensity aerobic exercise at least four 
days a week. In addition, you are free of metabolic, cardiovascular, and orthopedic 
limitations. The study is being conducted under the direction of Dean Jacks, Ph.D., 
Assistant Professor for the Department of Health & Sport Sciences and Mandy Jacobs, 
B.S., graduate student. Approximately twelve local subjects will be invited to participate. 
Your participation in this study will consist of three separate sessions on three different 
days. 
Purpose 
The purpose of this study is to investigate the effects of glutamine supplementation on 
maximal perfonnance during high-intensity exercise and on recovery from high-intensity 
exercise. 
Procedures 
Your participation in this study will consist of three separate sessions. You will be asked 
to abstain from any dietary supplementation and maintain current levels of exercise for 
the duration of the study. The first session will last approximately one-hour and will 
consist of completing a health survey and questionnaire which ask about your physical 
activity habits, supplementation history and recent illness and/or injuries. You may 
decline to answer any questions that make you feel uncomfortable. To assess general and 
overall body composition, height, weight, and skin folds will be taken. In addition, your 
resting heart rate and blood pressure will be measured. You will then be asked to 
complete and tum in a 3-day food diary before the first day of exercise testing. The food 
diary should include dietary intake for two weekdays and one weekend day. We will 
explain how to complete the food diary at the end of the first session and give you 
examples to take home. 
The second and third sessions will last approximately 4 hours and a minimum of 7 days 
should exist between the second and third testing session. You will be asked to fast 2-
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hours prior to reporting the laboratory for each testing session. In addition, you will be 
asked not to perfonn any exercise prior to reporting to the laboratory. Before the second 
testing session, you will be randomly assigned to one of two treatments, however you 
will not be infonned as to which treatment you have been assigned. Treatment 
assignments will be made using randomization which is a process similar to "flipping a 
coin". One group will participate in the experimental condition during the second testing 
session and the control condition the third testing session. The second group will 
participate in the control condition during the second testing session and the experimental 
condition during the third testing session. 
Upon reporting to the laboratory for the second and third testing sessions, we will 
measure your resting blood pressure and heart rate. A research registered nurse trained 
and credentialed in intravenous catheter placement will then insert a temporary catheter 
into a vein on the back of your hand. The catheter is similar to an intravenous catheter 
used to collect blood samples and administer intravenous medications. This catheter will 
be used to draw blood before exercise, during exercise and after exercise testing. A 
maximum of ten blood samples will be obtained throughout each testing session. The 
blood samples will be allowed to clot and then centrifuged for 20-30 minutes in order to 
separate the serum from the cellular components. The serum will then be pipette 
transferred to storage tubes and stored at -70F for future analysis. Specifically, we will be 
analyzing the blood samples for glutamine, glutamate, alanine and lactate concentrations. 
The samples will be stored for approximately 7 months before analysis is conducted. 
After analysis is conducted, blood samples will be destroyed. 
You will then be asked to drink 0.03 g/kg of body weight of glutamine mixed with 250 
ml of caffeine-free fruit juice or 250 ml of caffeine-free fruit juice (placebo). You will be 
given IO-minutes to consume the drink, which will be premixed by a research assistant. 
You will then rest for I-hour in the sitting position. After I-hour you will perfonn a 
maximal exercise test on the treadmill. The exercise test will consist of incremental 
increases in workload and is designed to induce fatigue within 8-14 minutes. Upon 
completion ofthe exercise test you will be asked to sit in a chair for I-hour. In order to 
measure expired gases during and after the exercise test, you will be asked to wear a 
headpiece and mouthpiece that is comparable to a snorkel. At the commencement of 1-
hour, a research nurse will remove the catheter from your hand and a research assistant 
will remove the headpiece and mouthpiece. Additionally, you will be asked to provide a 
urine sample pre-and post-exercise. All blood and urine samples will be de-identified 
(your name will not be linked to the samples), thus if you withdraw from the study, 
specimens cannot be destroyed. 
Potential Risks 
There are known physical risks linked with high-intensity exercise. Physical risks 
include elevated heart rate, muscle fatigue, and shortness of breath. In rare instances, 
high-intensity exercise may lead to cardiac events and/or death. It is likely (greater than 
40%) that you will experience elevated heart rate, muscle fatigue and shortness of breath. 
In rare instances (less than 1%) high-intensity exercise may lead to cardiac events 
and/or death. There are known physical risk linked with having blood drawn. Risk may 
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include excessive bleeding, fainting or feeling light headed, hematoma (blood 
accumulating under the skin) and infection. To date, oral supplementation of glutamine 
have not demonstrated any side effects when taken in small dosages. Glutamine has 
shown to be well tolerated in healthy subjects when administered orally in small dosages 
and is readily metabolized and cleared from the body. Non physical risk (psychological, 
social, economic, legal) are not anticipated with this study. However, you may suffer 
harms that we have not seen before. 
Benefits 
It is not clear that you will benefit directly from this study, but it is hoped that your 
participation will help others in the future. 
Alternatives 
Instead of taking part in this study, you could choose to not participate as a subject in this 
study. 
Research Related Injury 
If you are injured by being in this research study, the study doctor will arrange for you to 
get medical treatment. The sponsor, the study site, or your study doctor has not set aside 
money to pay for treatment of any injury. You and your insurance will be billed for the 
treatment of these injuries. Before you agree to take part in this research study you should 
find out whether your insurance will cover an injury in this kind of research. You should 
talk to the study doctor or staff about this. If you are injured, there is no money set aside 
for lost wages, discomfort, disability, etc. You do not give up your legal rights by signing 
this form. If you think you have a research related injury, please call your study doctor. 
Compensation 
You will not be compensated for your time, inconvenience, or expenses while you are in 
this study. 
Costs 
There will be no additional costs to you for participating. However, you.or your insurance 
company will be billed for all office visits and procedures that are part of routine medical 
care. It is your responsibility to find out what costs, if any, your insurance company will 
cover before taking part in the study. 
HIP AA Research Authorization 
The Health Insurance Portability and Accountability Act of 1996 (HIP AA) provides 
federal safeguards for protected health information (PHI). Examples of PHI are your 
name, address, and birth date. PHI may also include your medical history, results of 
health exams and lab tests, drugs taken and results of this research study. Your PHI 
cannot be used or shared without your agreement, unless it meets one of the HIP AA 
exceptions. You will be asked to sign a "Research Authorization" form. This allows the 
use and sharing of your PHI by those listed in the "Research Authorization." 
Confidentiality 
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Total privacy cannot be guaranteed. We will protect your privacy to the extent pennitted 
by law. If the results from this study are published, your name will not be made public. 
The following may look at your research and medical records: 
*The University of Louisville Institutional Review Board, Human Subjects Protection 
Program Office, Privacy Office and others involved in research administration at the 
University. 
*People who are responsible for research and HIP AA oversight at the institutions where 
the research is conducted. 
-Government agencies, such as: Office for Human Research Protections (OHRP), Office 
of Civil Rights, and other appropriate regulatory government agencies. 
Security 
All data will be protected from disclosure by being kept in a locked file and all 
identifying infonnation will be excluded from data fonns. In addition, blood and urine 
samples will be de-identified (your name will not be linked to the samples), thus if you 
withdraw from the study, specimens cannot be destroyed. 
V oluntary Participation 
Taking part in this study is completely voluntary. You may choose not to take part at all. 
If you decide not to be in this study, you won't be penalized or lose any benefits for 
which you qualify. If you decide to be in this study, you may change your mind and stop 
taking part at any time. If you decide to stop taking part, you won't be penalized or lose 
any benefits for which you qualify. You will be told about any new infonnation learned 
during the study that could affect your decision to continue in the study. 
Termination 
Your study doctor has the right to stop this study at any point. Your study doctor may 
take you out of this study with or without your okay. Reasons why this may occur 
include: failure to follow the experimental procedures and instructions provided by the 
investigators and failure to attend the experimental sessions. If you wish to withdraw 
from the study, there will be no consequences to you. We only ask that you tell us of your 
desire to stop participation in the study and you will be immediately withdrawn from the 
study. 
Participation in Other Research Studies 
You may not take part in this study if you are currently in another research study. It is 
important to let your doctor know if you are in another research study. 
Contact Persons 
Dean Jacks, Ph.D. at (502) 852-8352. 
Research Subject's Rights 
If you have any questions about your rights as a research subject, you may call the 
Human Subjects Protection Program Office at (502) 852-5188. You can discuss any 
questions about your rights as a research subject, in private, with a member of the 
Institutional Review Board (IRB). 
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You may also call this number if you have other questions about the research, and you 
cannot reach the study doctor, or want to talk to someone else. The IRB is an independent 
committee made up of people from the University community, staff of the institutions, as 
well as people from the community not connected with these institutions. The IRB has 
reviewed this research study. 
Concerns and Complaints 
If you have concerns or complaints about the research or research staff and you do not 
wish to give your name, you may call 1-877-852-1167. This is a 24 hour hot line 
answered by people who do not work at the University of Louisville. 
Acknowledgment and Signatures 
This informed consent document is not a contract. This document tells you what will 
happen during the study if you choose to take part. Your signature indicates that this 
study has been explained to you, that your questions have been answered, and that you 
agree to take part in the study. You are not giving up any legal rights by signing this 
informed consent document. You will be given a signed copy of this consent form to 
keep for your records. 
Do you want your primary care physician notified that you are a subject in this study? 
DYes DNo 
Printed Name of Subject/Legal Representative Signature of Subject/Legal Representative Date Signed 
Printed Name of Person Explaining Consent Form Signature of Person Explaining Consent Form Date Signed 
(if other than investigator) 
Printed Name ofInvestigator Signature of Investigator Date Signed 
*Note: If the investigator is not the person explaining the consent form, then the 
investigator must sign the Informed Consent Document within two weeks of the subject or 
subject's legal representative. 
Specimen Informed Consent 
Title of the research study: The effects of glutamine supplementation on maximal 
performance and recovery from high-intensity exercise. 
IRE assigned number: 07.0174 
Investigator(s) name & address: Jacks, Dean, Department of Health & Sport Sciences 
University of Louisville Crawford Gym, Room 114Louisville, Kentucky 40292 
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SUe(s) where study is to be conducted: Belknap Campus Laboratory, Laboratory 
Phone number for subjects to call for questions: If you have any questions, concerns, or 
complaints about the research study, please contact Dean Jacks at (502) 852-8352. 
Introduction and Background Information 
You are invited to participate in a research study. The study is being conducted by Dr. 
Dean Jacks, Ph.D., Assistant Professor for the Department of Health & Sport Sciences 
and Mandy Jacobs, B.S, graduate student. The study is sponsored by the University of 
Louisville, Department of Health & Sport Sciences. The study will take place at 
Crawford Gym on Belknap Campus. Approximately 12 local subjects will be invited to 
participate. Your participation in this study will consist of three separate sessions on three 
different days. 
Purpose 
The purpose of this research study is to investigate the effects of glutamine 
supplementation on maximal performance during high-intensity exercise and on 
recovery from high-intensity exercise. Glutamine is an amino acid that is found in most 
naturally occurring food proteins. 
Procedures 
A research registered nurse trained and credentialed in intravenous catheter placement 
will insert a temporary catheter into a vein on the back of your hand. The catheter is 
similar to an intravenous catheter used to collect blood samples and administer 
intravenous medications. Approximately 5.5 tablespoons of blood will be removed from 
your vein for the experimental purpose of determining the concentrations of various 
amino acids (glutamine, alanine, glutamate) and lactate, which is a byproduct of exercise. 
A tourniquet will be placed on your arm, a needle placed in your vein, and approximately 
5.5 tablespoons of blood will be removed. The blood will be removed intermittently, 
meaning not all of the blood will be removed at once. About 1.5 teaspoons of blood will 
be removed at a time, resulting in a maximum of 10 separate blood draws. The blood 
samples will be allowed to clot and then centrifuged for 20-30 minutes in order to 
separate the serum from the cellular components. The serum will then be pipette 
transferred to storage tubes and stored at -70F for future analysis. In addition, you will be 
asked to provide a urine sample pre- and post-exercise testing. The samples will be 
stored for approximately 7 months before analysis is conducted. All samples will be de-
identified (your name will not be linked to the samples), thus if you withdraw from the 
study, specimens cannot be destroyed. Once all analyses have been conducted, the 
samples will be destroyed. 
Risks 
There may be some pain or discomfort during the procedure. It is possible there may be 
some bleeding, bruising or infection at the puncture site. 
Benefits 
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The possible benefits of this study include more infonnation about the efficacy of 
glutamine as an ergogenic aid. The infonnation collected may not benefit you directly. 
The infonnation learned in this study may be helpful to others. 
Compensation 
You will not be compensated for your time, inconvenience, or expenses while you are in 
this study. 
Costs 
There will be no additional costs to you for participating. However, you or your insurance 
company will be billed for all office visits and procedures that are part of routine medical 
care. It is your responsibility to find out what costs, if any, your insurance company will 
cover before taking part in the study. 
HIP AA Research Authorization 
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) provides 
federal safeguards for protected health infonnation (PHI). Examples of PHI are your 
name, address, and birth date. PHI may also include your medical history, results of 
health exams and lab tests, drugs taken and results of this research study. Your PHI 
cannot be used or shared without your agreement, unless it meets one of the HIP AA 
exceptions. You will be asked to sign a "Research Authorization" fonn. This allows the 
use and sharing of your PHI by those listed in the "Research Authorization." 
Security 
All data will be protected from disclosure by being kept in a locked file and all 
identifying 
infonnation will be excluded from data fonns. In addition, blood and urine samples will 
be de-identified (your name will not be linked to the samples), thus if you withdraw from 
the study, specimens cannot be destroyed. 
Voluntary Participation 
Taking part in this study is completely voluntary. You may choose not to take part at all. 
If you decide not to be in this study, you won't be penalized or lose any benefits for 
which you qualify. If you decide to be in this study, you may change your mind and stop 
taking part at any time. If you decide to stop taking part, you won't be penalized or lose 
any benefits for which you qualify. 
Termination 
Your study doctor has the right to stop this study at any point. Your study doctor may 
take you out of this study with or without your okay. Reasons why this may occur 
include: failure to follow the experimental procedures and instructions provided by the 
investigators and failure to attend the experimental sessions. If you wish to withdraw 
from the study, there will be no consequences to you. We only ask that you tell us of your 
desire to stop participation in the study and you will be immediately withdrawn from the 
study. 
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Participation in Other Research Studies 
You may not take part in this study if you are currently in another research study. It is 
important to let your doctor know if you are in another research study. 
Confidentiality 
Total privacy cannot be guaranteed. We will protect your privacy to the extent permitted 
by law. If the results from this study are published, your name will not be made public. 
The following may look at your research and medical records: 
*The University of Louisville Institutional Review Board, Human Subjects Protection 
Program Office, Privacy Office and others involved in research administration at the 
University. 
*People who are responsible for research and HIP AA oversight at the institutions where 
the research is conducted. 
*Government agencies, such as: Office for Human Research Protections (OHRP), 
Office of Civil Rights, and other appropriate regulatory government agencies. 
Contact Persons 
If you have any questions, concerns, or complaints about the research study, please 
contact Dean Jacks at (502) 852-8352. 
Research Subject's Rights 
If you have any questions about your rights as a research subject, you may call the 
Human Subjects Protection Program Office at (502) 852-5188. You can discuss any 
questions about your rights as a research subject, in private, with a member ofthe 
Institutional Review Board (IRB). You may also call this number if you have other 
questions about the research, and you cannot reach the study doctor, or want to talk to 
someone else. The IRB is an independent committee made up of people from the 
University community, staff of the institutions, as well as people from the community not 
connected with these institutions. The IRB has reviewed this research study. 
Concerns and Complaints 
If you have concerns or complaints about the research or research staff and you do not 
wish to give your name, you may call 1-877-852-1167. This is a 24 hour hot line 
answered by people who do not work at the University of Louisville .. 
Acknowledgment and Signatures 
This informed consent document is not a contract. This document tells you what will 
happen during the study if you choose to take part. Your signature indicates that this 
study has been explained to you, that your questions have been answered, and that you 
agree to take part in the study. You are not giving up any legal rights by signing this 
informed consent document. You will be given a signed copy of this consent form to 
keep for your records. 
Printed Name of Subject/Legal Representative Signature of Subject/Legal Representative Date Signed 
Printed Name of Person Explaining Consent Form Signature of Person Explaining Consent Form Date Signed 
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(if other than investigator) 
Printed Name of Investigator Signature of Investigator Date Signed 
*Note: If the investigator is not the person explaining the consent form, then the 
investigator must sign the Informed Consent Document within two weeks of the subject or 
subject's legal representative. 
Consent version date: 1112612007 
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APPENDIXD 
Instrnctions for 3-Day Nutritional Diary 
• Record everything you consume for 3 days (1 weekend day, 2 week days) in the 
logs provided. Be sure to include the date on each dietary log. 
• 'Amount' - In this space indicate the amount of the particular food/drink item 
you ate/drank. Estimate the size (2"x 1"x 1 "), the volume (112 cup), the weight (2 
ounces) and/or the number of items (12) of that type of food/drink. 
• 'What Kind' - In this column, write down the type of food/drink you ate/drank. 
Don't forget to write down extras, such as candy, butter, alcohol and sugar. 
• 'Brand' - In this space indicate the brand of the particular food/drink you 
ate/drank. 
• 'Time' - Write down the time of day you ate/drank the food/drink. 
• Be sure to note if you were taking any medication, vitamins, supplements, etc. in 
the space provided. 
Tips for Keeping a Nutritional Diary 
1. Write down EVERYTHING 
Keep your form with you all day and write down everything you eat and drink. A 
piece of candy, a handful of pretzels, a can of soda or small cookie may not seem like 
much at the time, but over 3 days these calories add up. 
2. DoitNOW 
Don't depend on your memory at the end of the day. Record your eating/drinking as 
you go. 
3. Be SPECIFIC 
Make sure to include extras, such as ketchup, salad dressing, gravy, pickles on your 
sandwich, etc. Also include how the item was prepared - fried, baked, breaded, 
scrambled, steamed, etc. 
4. Estimate amounts 
Remember, a fist = 1 cup; palm or deck of cards = 3 oz.; handful = 1-2 oz. 
5. Tell the Truth 
There's nothing to be gained by trying to look good on these forms. Do not change 
your eating habits while you're keeping your food diary. 
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Th D Nt" ID' ree- ay u ntiona larr 
Food or Drink 
Amount What Kind Brand Time 




TIME SPEED GRADE(%) 
(minutes) (mph) 
3 1.7 4.0 
6 2.5 6.5 
9 3.4 10.0 
12 4.2 12.5 
15 5.0 15.0 
18 5.5 17.5 
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APPENDIXF 
Category Scale for Ratings of Perceived Exertionl7 
6 
7 Very, very light 
8 
9 Very light 
10 
11 Fairly light 
12 




17 Very hard 
18 




Power & Sample Size Analysis 
n = 7 (6 males & 1 female) Power Ana1ysis* 
V02max 0.078 
5-minP V02 0.059 
10-minP V02 0.071 
30-minP V02 0.077 
60-minP V02 0.096 
Stage 1 CO2 0.057 
Stage 2 C02 0.096 
Stage 3 CO2 .253 
Stage 4 C02 0.088 
5-minP C02 0.058 
10-minP C02 0.094 
30-minP CO2 0.060 
60-minP C02 0.074 
Max RER 0.051 
5-minP RER 0.551 
lO-minP RER 0.155 
30-minP RER 0.072 

















































































n = 6 (Males) Power Analysis Sample Size Calculation 
V02max 0.071 21 
5-minP V02 0.065 29 
lO-minP V02 0.11 8 
30-minP V02 0.075 18 
60-minP V02 0.063 34 
Stage 1 CO2 0.080 15 
Stage 2 CO2 0.108 8 
Stage 3 CO2 0.252 2 
Stage 4 CO2 0.105 13 
5-minP CO2 0.058 56 
lO-minP CO2 0.117 7 
30-minP CO2 0.065 29 
60-minP CO2 0.051 548 
MaxRER 0.051 573 
5-minP RER 0.552 1 
lO-minP RER 0.255 2 
30-minP RER 0.065 2 
60-minP RER 0.156 4 
3-minE HR X X 
6-minE HR 0.118 7 
9-minEHR 0.071 18 
12-minE HR 0.155 4 
EndHR 0.078 16 
I-minP HR 0.061 40 
3-minP HR 0.055 95 
5-minP HR X X 
lO-minP HR 0.052 251 
30-minP HR 0.077 17 
60-minP HR 0.051 589 
3-minE RPE 0.071 21 
6-minE RPE 0.066 27 
9-minE RPE 0.071 22 
12-minE RPE 0.052 186 
EndRPE 0.369 I 
Pre Urine 0.063 33 
Post Urine 0.053 143 
Pre Saliva 0.059 118 
Post Saliva 0.158 4 
V02= volume of 02 consumption; P = post-exercise; Stage 1 = average of minutes 2-3; 
Stage 2 = average of minutes 5-6; Stage 3= average of minutes 8-9; Stage 4= average of 
minutes 11-12; E = during exercise; End = upon completion of exercise; Pre = I-hour 
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